BSPED2018

    07:45 - 08:45 
    Sponsored Symposium
    08:00 - 19:00 
    Registration
    08:45 - 09:00 
    Endocrine Main Meeting: Welcome from Convenors
    The Studio
    08:45
    The Studio
    Session starts at 08:45
    Welcome from Convenors

    09:00 - 10:30 
    Endocrine Main Meeting: Oral Communications 4
    The Studio
    Mehul Dattani (London) & Helen Storr (London)
    09:10
    The Studio
    Session starts at 09:00
    OC4.1
    Hydrocortisone granules in capsules for opening: phase 3 trial in children with adrenal insufficiency and long-term safety data
    Alexander Lewis (Cardiff)

    09:20
    The Studio
    Session starts at 09:00
    OC4.2
    Gene expression signatures in children with growth hormone deficiency (GHD) and Turner syndrome (TS) predict response to growth hormone
    Adam Stevens (Manchester)

    09:30
    The Studio
    Session starts at 09:00
    OC4.3
    Recommendations for management of paediatric phaeochromocytoma/paraganglioma (PCC/PGL):On behalf of the UK Paediatric PCC/PGL Guideline Development Group.
    Prateek Yadev (London)

    09:40
    The Studio
    Session starts at 09:00
    OC4.4
    Identification and characterisation of a small-molecule ACTH receptor/Melanocortin-2-receptor antagonist
    Li Chan (London)

    09:50
    The Studio
    Session starts at 09:00
    OC4.5
    Delayed or Absent? - Use of Next Generation Sequencing Diagnostic Tools in a UK Puberty Cohort
    Sasha Howard (London)

    10:00
    The Studio
    Session starts at 09:00
    OC4.6
    Implementation of a novel non-invasive test for monitoring control in individuals with congenital adrenal hyperplasia
    Irina Bacila (Sheffield)

    10:10
    The Studio
    Session starts at 09:00
    OC4.7
    Clinical Outcomes of Focal Congenital Hyperinsulinism - A UK Perspective

    10:20
    The Studio
    Session starts at 09:00
    OC4.8
    Prolactinoma in Childhood and Adolescence – outcomes relating to the size of tumour
    Ved Bhushan Arya (London)

    09:00 - 10:30 
    Diabetes Professionals Day: Session 1
    The Suites
    Lesley Drummond (Birmingham)
    09:00
    The Suites
    Session starts at 09:00
    S1.1
    Diasend Project
    John Pemberton (Birmingham)

    09:30
    The Suites
    Session starts at 09:00
    S1.2
    Social media and diabetes management - does it work?
    Libby Dowling (London)

    10:00
    The Suites
    Session starts at 09:00
    S1.3
    Optimising Transition in Young Adults with Diabetes - the importance of hope?

    09:00 - 09:45 
    Endocrine Main Meeting - Nurses' AGM
    Stephanie Kerr (Southampton) & Kate Davies (London)
    09:45 - 10:30 
    PENS Presentation Session
    Stephanie Kerr (Southampton) & Kate Davies (London)
    09:45

    Session starts at 09:45
    PENS1.1
    Polycystic Kidney Disease with Hyperinsulinemic hypoglycaemia
    Kate Morgan (London)

    10:05

    Session starts at 09:45
    PENS1.2
    PENS BSPED Prize: The Implementation of a Nurse Led Virtual Thyroid Clinic
    Christine Desmond (Reading)

    10:30 - 11:00 
    Tea & Coffee
    Mezzanine
    11:00 - 11:30 
    Diabetes Professionals' Day: Oral Communications 6
    The Suites
    Ruth Krone (Birmingham) & Heather Stirling (Coventry)
    11:00
    The Suites
    Session starts at 11:00
    OC6.1
    A Retrospective Regional Analysis of Outcomes during Transition of Young People with Type 1 Diabetes
    Melanie Kershaw (Birmingham)

    11:10
    The Suites
    Session starts at 11:00
    OC6.2
    Perceptions of diabetes education: a questionnaire-based survey of 117 patients and families.
    Allison Low (Sheffield)

    11:20
    The Suites
    Session starts at 11:00
    OC6.3
    Has the reduction in maintenance fluid rates following introduction of 2015 BSPED-recommended diabetic ketoacidosis guidelines impacted on complication rates?
    Amish Chinoy (Manchester)

    11:00 - 12:30 
    Symposium 1
    DSD/Adrenals
    The Studio
    Jeremy Kirk (Birmingham)
    11:00
    The Studio
    Session starts at 11:00
    SY1.1
    Diagnostic approach to expanding aetiologies of DSD
    Nils Krone (Sheffield)

    11:30
    The Studio
    Session starts at 11:00
    SY1.2
    DSD surgery; the child’s best interests, and disclosure prior to consent
    Robert Wheeler (Southampton)

    12:00
    The Studio
    Session starts at 11:00
    SY1.3
    Novel androgen pathways and their role in CAH
    Wiebke Arlt (Birmingham)

    11:30 - 12:30 
    Diabetes Professionals Day: Session 2
    Type II diabetes
    The Suites
    Martha Ford-Adams (London)
    11:30
    The Suites
    Session starts at 11:30
    S2.1
    Type 2 diabetes: insights from the adult clinic
    Katharine Owen (Oxford)

    12:00
    The Suites
    Session starts at 11:30
    S2.2
    New Therapies in Type 2 diabetes
    Billy White (London)

    12:30 - 13:30 
    Lunch, exhibition & poster tours
    Mezzanine
    13:30 - 14:30 
    Diabetes Professionals: Session 3
    Technology in Diabetes
    The Suites
    Chizo Agwu (Birmingham)
    13:30
    The Suites
    Session starts at 13:30
    S3.1
    CGMS in children - current technologies and future prospects
    Carlo Acerini (Cambridge)

    14:00
    The Suites
    Session starts at 13:30
    S3.2
    Practical Approach to Management of CGM and Flash Glucose (Libre) Systems for Children and Young People with T1DM
    May Ng (Ormksirk)

    13:30 - 14:30 
    Endocrine Main Meeting: Oral Communications 5
    The Studio
    Ved Bhusan Arya (London) & Liz Crowne (Bristol)
    13:30
    The Studio
    Session starts at 13:30
    OC5.1
    Growth outcomes in adolescents and adults with Silver-Russell syndrome and the effects of childhood growth hormone treatment.
    Oluwakemi Lokulo-Sodipe (Southampton)

    13:36
    The Studio
    Session starts at 13:30
    OC5.2
    Screening for Co-Morbidities in Fibrous Dysplasia
    Zilla Huma (London)

    13:42
    The Studio
    Session starts at 13:30
    OC5.3
    Can novel stem cell models help unpick the pathogenesis of the Triple A Syndrome?

    13:48
    The Studio
    Session starts at 13:30
    OC5.4
    Fourteen years experience of hydrocortisone pump therapy for cortisol replacement in adrenal insufficiency
    Peter Hindmarsh (London)

    13:54
    The Studio
    Session starts at 13:30
    OC5.5
    New insights into the Low Dose Dexamethasone Suppression Test in paediatric Cushing’s Syndrome (CS)

    14:00
    The Studio
    Session starts at 13:30
    OC5.6
    Successes and challenges around cohorted introduction of Burosumab in clinical treatment of X-Linked Hypophosphataemia (XLH)
    Ian Tucker (Bristol)

    14:06
    The Studio
    Session starts at 13:30
    OC5.7
    A novel GHR pseudoexon mutation causing frameshift and severe postnatal growth failure
    Emily Cottrell (London)

    14:12
    The Studio
    Session starts at 13:30
    OC5.8
    Patients with short stature and GH/IGF-1 Insensitivity harbour Copy Number Variants causing a Silver-Russell-like Phenotype
    Emily Cottrell (London)

    14:18
    The Studio
    Session starts at 13:30
    OC5.9
    Diazoxide-induced pulmonary hypertension: UK multicentre retrospective study on the risk factors, monitoring approach andmanagement recommendations
    Suet Ching Chen (Glasgow)

    14:30 - 15:30 
    Tea, coffee & poster tours
    Mezzanine
    15:30 - 16:30 
    Symposium 2
    Bone health and disease
    The Studio
    Paul Arundel (Sheffield)
    15:30
    The Studio
    Session starts at 15:30
    SY2.1
    Vitamin D - Beyond Bone
    Martin Hewison (Birmingham)

    16:00
    The Studio
    Session starts at 15:30
    SY2.2
    State of the Art Lecture: 20 years experience in Metabolic Bone
    Nicholas Shaw (Birmingham)

    15:30 - 16:30 
    Diabetes Professionals Day: Session 4
    Debate
    The Suites
    Melanine Kershaw (Birmingham)
    15:30
    The Suites
    Session starts at 15:30
    S4.1
    FOR: This house believes that Automation has primacy over Education in management of diabetes
    Tabitha Randell (Nottingham)

    16:00
    The Suites
    Session starts at 15:30
    S4.2
    AGAINST: This house believes that Automation has primacy over Education in management of diabetes
    Fiona Campbell (Leeds)

    16:30 - 17:00 
    Key Note Speaker: Session 5
    Bone health and disease
    The Studio
    16:30
    The Studio
    Session starts at 16:30
    S5
    Palaeopathology; diseases and excavations
    Anthony Waldron (London)

    16:30 - 17:00 
    Key Note Speaker: Session 5
    Bone health and disease
    The Studio
    16:30
    The Studio
    Session starts at 16:30
    S5
    Palaeopathology; diseases and excavations
    Anthony Waldron (London)

    17:15 - 18:15 
    BSPED AGM
    The Studio